HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antagonizing astrocytic platelet activating factor receptor-neuroinflammation for total flavone of epimedium in response to cuprizone demyelination.

Abstract
Demyelinating diseases of the central nervous system are characterized by recurrent demyelination and progressive neurodegeneration, but there are no clinical drugs targeting myelin regeneration or improving functional disability in the treatment of multiple sclerosis. Total flavone of Epimedium (TFE) is the main active components of Epimedium, which exhibits the beneficial biological activities in the treatment of diseases, but there is no report in the treatment of demyelinating disorder. The purpose of this study was to explore the therapeutic potential and possible mechanism of TFE in the treatment of demyelination. The results showed that TFE efficiently improved the behavioural performance and histological demyelination in cuprizone (CPZ)-induced demyelinating model. In terms of action, TFE increased astrocytes enrichment in corpus callosum, striatum and cortex, and promoted astrocytes to express neurotrophic factors. Furthermore, the expression of platelet-activating factor receptor (PAFR) in astrocytes was induced by CPZ feeding and LPS stimulation, accompanied by the increase of inflammatory cytokines TNF-α,IL-6 and IL-1β. TFE declined the expression of PAFR, and inhibited inflammatory response. At the same time, TFE also antagonized PAFR activation and inflammatory response triggered by PAF, which further confirmed that TFE, as a new PAFR antagonist, inhibited the astrocyte-derived inflammatory response by antagonizing PAFR-neuroinflammation axis, thus contributing to myelin protection and regeneration.
AuthorsZhao Meng-Ru, Sui Ruo-Xuan, Yu Ming-Yang, Tian Tong, Zhang Lei, Yang Ying-Bo, Xiao Bao-Guo
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 101 Issue Pt A Pg. 108181 (Dec 2021) ISSN: 1878-1705 [Electronic] Netherlands
PMID34607229 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier B.V.
Chemical References
  • Flavones
  • Plant Extracts
  • Platelet Membrane Glycoproteins
  • Receptors, G-Protein-Coupled
  • platelet activating factor receptor
  • Cuprizone
Topics
  • Administration, Oral
  • Animals
  • Astrocytes (drug effects, immunology, metabolism)
  • Cuprizone (administration & dosage, toxicity)
  • Demyelinating Diseases (chemically induced, drug therapy, immunology, pathology)
  • Disease Models, Animal
  • Epimedium (chemistry)
  • Flavones (pharmacology, therapeutic use)
  • Humans
  • Male
  • Mice
  • Myelin Sheath (drug effects, immunology, pathology)
  • Neuroinflammatory Diseases (chemically induced, drug therapy, immunology, pathology)
  • Plant Extracts (pharmacology, therapeutic use)
  • Platelet Membrane Glycoproteins (antagonists & inhibitors)
  • Receptors, G-Protein-Coupled (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: